Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Dose-comparison Trial of OPC-6535 in COPD
jRCT2080220742Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jun 2009
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of tetomilast in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Started Jun 2009; status: completed.
02
Drugs
tetomilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080220742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220742.